[ad_1]
Wikimedia
Insulin pumps with continuous monitoring have been clinically proven to reduce the risk of developing diabetes complications.
While it is true that insulin pump therapy is the most recommended therapeutic option for patients with type 1 diabetes
especially in children and adolescents, Access to treatment is limited in Latin American countries, however, Colombia is the only country in the region covered by the Compulsory Health Plan (SOP).
Due to social, economic, governmental and legal barriers, in most South American countries, conventional treatment of multiple injections remains the most commonly used.
In many cases, patient limitations on access to treatment include: delays in drug delivery, lack of knowledge
and a small number of trained and authorized prescribers the insulin pump.
In Colombia, insulin pumps are part of the mandatory plan However, it is necessary that patients rely on medical equipment and insurers to facilitate access to this treatment.
Overall, diabetes costs are expected to increase $ 592 billion by the year 2035. In 2013, expenditures for diabetes management accounted for 11% of the global health budget, according to data from the World Health Organization. ; WHO.
Studies in Colombia, Dr. Ana María Gómez, Medical Specialist in Internal Medicine and Endocrinology, Measured the Effectiveness of a More Sensory Insulin Pump Program in Type 1 Diabetes Patients life without complications, life expectancy, years adjusted for quality of life and, in addition, delays the onset of complications.
DIABETES WITHOUT LIMITS 2
Worldwide, recent publications show that insulin pump + sensor treatment and continuous follow-up versus treatment of multiple injections in patients with inadvertent hypoglycemia decreases Severe hypoglycaemia by 59% and increases the adequate glucose time by 17%.
It is necessary to consider that most cost-effectiveness studies of insulin pump therapy are estimated on the direct costs generated by treatment, but there are other indirect costs that need to be taken into account. to measure the economic impact of the disease.
These indirect costs relate to measures such as how much does a mother take to retire to take care of her child or how much it could cost a country a complication in a young person to prevent it? to live. By combining these costs with direct costs, we could talk about a very cost-effective therapy for health systems around the world.
Diabetic patients must continually monitor their glucose levels, which is why thanks to medical technology an alternative treatment
was created. It consists of a small sensor inserted under the patient's skin, which measures the glucose levels continuously, the sensor and / or the device is connected to a transmitter, which sends these data to an insulin pump and is therefore estimated
This device allows patients to see in real time the most relevant information and to set alerts and alarms to know when sensor glucose levels have dropped too much or increased significantly.
In addition to providing more accurate insulin intake and improving the quality of life of people with diabetes, it has been clinically proven that insulin pumps with continuous glucose monitoring provide better insulin delivery. control of blood glucose 1, which reduces the risk of presenting complications of diabetes, such as: cutaneous complications, hypertension problems, kidney damage, peripheral arterial disease, gastritis Oparesis, osteoporosis and bone and joint problems, amputations, badual problems , urological, among others.
In relation
[ad_2]
Source link
